0001593968-21-002284.txt : 20211020 0001593968-21-002284.hdr.sgml : 20211020 20211020122927 ACCESSION NUMBER: 0001593968-21-002284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211018 FILED AS OF DATE: 20211020 DATE AS OF CHANGE: 20211020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOSTER ANDREW B CENTRAL INDEX KEY: 0001285221 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36475 FILM NUMBER: 211333253 BUSINESS ADDRESS: STREET 1: 440 CLYDE AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509305282 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEMETIS, INC CENTRAL INDEX KEY: 0000738214 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 261407544 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 408-517-3304 MAIL ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: AE BIOFUELS, INC. DATE OF NAME CHANGE: 20110714 FORMER COMPANY: FORMER CONFORMED NAME: AE Biofuels, Inc. DATE OF NAME CHANGE: 20071212 FORMER COMPANY: FORMER CONFORMED NAME: MARWICH II LTD DATE OF NAME CHANGE: 19840123 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-10-18 0000738214 AEMETIS, INC AMTX 0001285221 FOSTER ANDREW B 20400 STEVENS CREK BLVD, SUITE 700 CUPERTINO CA 95014 false true false false Executive Vice President Common Stock 2021-10-18 4 M false 27833 0.7 A 27833 D Common Stock 2021-10-18 4 M false 10000 0.92 A 37833 D Common Stock 2021-10-18 4 M false 8334 0.86 A 46167 D Common Stock 2021-10-18 4 M false 25000 0.6 A 71167 D Common Stock 2021-10-18 4 S false 27833 18.0671 D 43334 D Common Stock 2021-10-18 4 S false 10000 17.7847 D 33334 D Common Stock 2021-10-18 4 S false 25000 17.7834 D 8334 D Common Stock 2021-10-18 4 S false 8334 17.8452 D 0 D Option (right to buy) 0.70 2021-10-18 4 M false 27833 0 D 2019-04-08 2029-01-07 Common stock and Series B Preferred 27833 27955 D Option (right to buy) 0.92 2021-10-18 4 M false 10000 0 D 2019-09-06 2029-06-05 Common stock and Series B Preferred 10000 16696 D Option (right to buy) 0.86 2021-10-18 4 M false 8334 0 D 2020-04-09 2030-01-09 Common stock and Series B Preferred 8334 51887 D Option (right to buy) 0.60 2021-10-18 4 M false 25000 0 D 2020-06-28 2030-03-28 Common stock and Series B Preferred 25000 88581 D These shares were sold pursuant to a Rule 10b5-1 plan. /s/Todd Waltz attorney-infact 2021-10-20